Skip to main content
Clinical Trials/JPRN-UMIN000028788
JPRN-UMIN000028788Completed未知

Clinical study of sensory evaluation using edoxaban orally disintegrating tablet (OD tablet) - Sensory evaluation study of edoxaban OD tablet

Daiichi Sankyo Co., Ltd. Medical Science Department0 sites100 target enrollmentStarted: August 24, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)Patients who are taking dual anti-platelet therapy. 2)Patients who have experienced any cardiovascular events (stroke, myocardial infarction, cardiac intervention for cardiac events other than myocardial infarction, or heart failure requiring hospitalization) or any bleeding leading to hospitalization within two weeks before enrollment. 3) Patients who are pregnant or breast-feeding, or who have possibility to be pregnant. 4) Patients who are judged unsuitable for this study by the investigators.

Investigators

Sponsor
Daiichi Sankyo Co., Ltd. Medical Science Department

Similar Trials